Prediction of early biochemical and symptomatic hypocalcemia in thyroid cancer patients after total thyroidectomy
- PMID: 40810972
- DOI: 10.1007/s12020-025-04357-x
Prediction of early biochemical and symptomatic hypocalcemia in thyroid cancer patients after total thyroidectomy
Abstract
Purpose: Hypocalcemia is a common complication after total thyroidectomy (TT). Several studies have identified risk factors for early biochemical hypocalcemia, nevertheless, the noteworthy symptomatic hypocalcemia has not been considered. This study aims to construct an intuitive predictive model for biochemical and symptomatic hypocalcemia to assist individualized management.
Methods: A retrospective study was conducted on thyroid cancer patients undergoing TT. Two separate patient cohorts were used for model development and external validation, respectively. Data were gathered to identify the risk factors for biochemical (serum calcium <8.0 mg/dL) and symptomatic hypocalcemia by logistic regression. A predictive model was visualized by a nomogram and validated internally and externally.
Results: Of 431 patients studied, 258 (59.9%) developed hypocalcemia including 180 with biochemical hypocalcemia and 196 with symptomatic hypocalcemia, of whom 118 patients had both. Female (OR 2.108, 95% CI 1.166-3.812, P = 0.014) and postoperative PTH decreased ratio ≥ 60% (OR 22.489, 95% CI 13.289-38.058, P < 0.001) were independent risk factors for hypocalcemia, while BMI ≥ 24 kg/m2 (OR 0.567, 95% CI 0.331-0.970, P = 0.038) was a protective factor. Besides, Hashimoto's thyroiditis tended to increase the risk of hypocalcemia (P = 0.082). A nomogram was developed and a predicted probability of exceeding 0.55 suggested a higher risk of hypocalcemia with a sensitivity of 81.8% and a specificity of 82.1%. The internal and external validated areas under the curve (AUC) were 0.860 and 0.862, respectively.
Conclusion: The validated nomogram combining gender, BMI and proportion of PTH reduction may guide the risk identification and stratified management of hypocalcemia after total thyroidectomy.
Keywords: Hypocalcemia; Nomogram; Risk prediction; Thyroid cancer; Total thyroidectomy.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: The authors declare no competing interests. Ethical approval: This study was conducted in compliance with the Declaration of Helsinki of the World Medical Congress and was approved by the medical ethics committee of the Nanjing Drum Tower Hospital.
Similar articles
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12. Clin Orthop Relat Res. 2024. PMID: 37306629 Free PMC article.
-
The Impact of Glucocorticoid Treatment on Hypocalcemia Following Thyroid Surgery: A Systematic Review and Meta-Analysis.Endocr Res. 2024 Feb-May;49(2):77-85. doi: 10.1080/07435800.2023.2293103. Epub 2023 Dec 11. Endocr Res. 2024. PMID: 38078858
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- P. Sittitrai, D. Ruenmarkkaew, H. Klibngern et al., Perioperative versus postoperative calcium and vitamin D supplementation to prevent symptomatic hypocalcemia after total thyroidectomy: a randomized placebo controlled trial. Int. J. Surg. 109, 13–20 (2023). https://doi.org/10.1097/JS9.0000000000000192 . - DOI - PubMed - PMC
-
- D.M. Shoback, J.P. Bilezikian, A.G. Costa et al., Presentation of hypoparathyroidism: etiologies and clinical features. J. Clin. Endocrinol. Metab. 101, 2300–2312 (2016). https://doi.org/10.1210/jc.2015-3909 . - DOI - PubMed
-
- O. Edafe, R. Antakia, N. Laskar et al., Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br. J. Surg. 101, 307–320 (2014). https://doi.org/10.1002/bjs.9384 . - DOI - PubMed
-
- M. Mannstadt, J.P. Bilezikian, R.V. Thakker et al., Hypoparathyroidism. Nat. Rev. Dis. Prim. 3, 17055 (2017). https://doi.org/10.1038/nrdp.2017.55 . - DOI - PubMed
-
- L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J. Bone Miner. Res. 28, 2277–2285 (2013). https://doi.org/10.1002/jbmr.1979 . - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources